Mersana Back On Track After Speedy Changes To ADC Program

Following a clinical hold for its lead product, Mersana explains how it re-engineered the program and how it is developing its ADC platform further.

Train
Mersana hurtled toward its clinical hold lift in 60 days • Source: Shutterstock

More from Clinical Trials

More from R&D